Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Aptose Biosciences Inc.
DescriptionSmall molecule inhibitor of maternal embryonic leucine zipper kinase (MELK)
Molecular Target Maternal embryonic leucine zipper kinase (MELK)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today